What is Lifecore Biomedical Operating Cash Flow per Share?
Lifecore Biomedical's operating cash flow per share for the
three
months ended in Feb. 2025 was $0.03.
Lifecore Biomedical's operating cash flow per share for the trailing twelve months (TTM) ended in Feb. 2025 was $0.05.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the OCF Growth Rate using Operating Cash Flow per Share data.
The historical rank and industry rank for Lifecore Biomedical's Operating Cash Flow per Share or its related term are showing as below:
During the past 13 years, Lifecore Biomedical's highest 3-Year average Operating Cash Flow per Share Growth Rate was 74.70% per year. The lowest was -21.90% per year. And the median was 2.40% per year.
LFCR's 3-Year OCF Growth Rate is not ranked *
in the Drug Manufacturers industry.
Industry Median: 8.75 * Ranked among companies with meaningful 3-Year OCF Growth Rate only.
Lifecore Biomedical Operating Cash Flow per Share Historical Data
The historical data trend for Lifecore Biomedical's Operating Cash Flow per Share can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* Premium members only.
Lifecore Biomedical Operating Cash Flow per Share Chart
Competitive Comparison of Lifecore Biomedical's Operating Cash Flow per Share
For the Drug Manufacturers - Specialty & Generic subindustry, Lifecore Biomedical's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Lifecore Biomedical's Price-to-Operating-Cash-Flow Distribution in the Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Lifecore Biomedical's Price-to-Operating-Cash-Flow distribution charts can be found below:
* The bar in red indicates where Lifecore Biomedical's Price-to-Operating-Cash-Flow falls into.
Operating Cash Flow per Share for the trailing twelve months (TTM) ended in Feb. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.05
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Lifecore Biomedical Operating Cash Flow per Share Related Terms
Thank you for viewing the detailed overview of Lifecore Biomedical's Operating Cash Flow per Share provided by GuruFocus.com. Please click on the following links to see related term pages.
Lifecore Biomedical Inc is a fully integrated contract development and manufacturing organization (CDMO) that offers differentiated capabilities in the development, filling, and finishing of complex sterile injectable pharmaceutical products in syringes and vials. It manufactures injectable-grade Hyaluronic Acid. Lifecore recognizes revenue in two different product categories, CDMO and fermentation.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
LFCR has been successfully added to your 